GEOFFREY WEISMAN, M.D., PLLC
Ophthalmology Physician · HOLBROOK, NY
Individual Active NPI 1225107634
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 668 | 11,678 | $7,656,381 | $1,605,066 | $1,253,847 |
| 2023 | 823 | 25,581 | $9,532,637 | $2,217,456 | $1,740,665 |
| 2022 | 844 | 14,871 | $9,517,051 | $1,854,015 | $1,448,666 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 5,640 | $35 | $28 |
| 92134 | Imaging of retina | 1,274 | $47 | $34 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 901 | $148 | $118 |
| 67028 | Injection of drug into eye | 777 | $131 | $98 |
| J0177 | Injection, aflibercept hd, 1 mg | 736 | $325 | $259 |
| J0178 | Injection, aflibercept, 1 mg | 596 | $835 | $664 |
| 92014 | Established patient complete exam of visual system | 517 | $145 | $100 |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 364 | $106 | $81 |
| J2778 | Injection, ranibizumab, 0.1 mg | 273 | $168 | $133 |
| J3590 | Unclassified biologics | 128 | $1,226 | $977 |
| 92012 | Established patient problem focused exam of visual system | 124 | $102 | $45 |
| 92133 | Imaging of optic nerve | 111 | $42 | $29 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | 138665 | NY |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in New York
- NPI 1679237788
- NPI 1952845448
- NPI 1245863109
- NPI 1154091023
- NPI 1366075129
- NPI 1649467051
- NPI 1699878587
- NPI 1003078718
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.